66.9 F
New York
Thursday, October 1, 2020

The Forecast Just Changed on Abbott Laboratories (NYSE:ABT)

Must read

Qutoutiao Inc. (NASDAQ:QTT) on the Path to Ruin

Qutoutiao Inc. (QTT) shares are trading at lower $2.19 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Molson Coors Beverage Company (NYSE:TAP) is Gaining Momentum on Earnings Catalyst

Molson Coors Beverage Company (TAP) shares are trading at higher $33.56 and the avg recommendation for the stock is Moderate Buy, while the current...

Renewed Optimism is Surrounding Washington Prime Group Inc. (NYSE:WPG)

Washington Prime Group Inc. (WPG) shares are trading at higher $0.65 and the avg recommendation for the stock is Hold, while the current analyst...

Is Now the Time to Invest in Credit Suisse Group AG (NYSE:CS)?

Credit Suisse Group AG (CS) shares are trading at higher $9.97 and the avg recommendation for the stock is Moderate Buy, while the current...

The Abbott Laboratories (ABT) shares are trading at lower $99.08 and the avg recommendation for the stock is Strong Buy. while the current analyst price target stands at $101.93.

To add more color to this target, the company’s high over the last year is $100.00 and the low is $61.61. Over the last 52 weeks, ABT is down -0.92% while the S&P 500 is up 0.81%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, ABT reported a profit of $4.07 billion. Abbott Laboratories also saw revenues increase to $7.33 billion. In addition, ABT has free cash flow of $0.0 as of 06-2020.

ABT booked profit margins of 11.70%, its Return on Equity (ROE) is 11.80%, and its Return on Assets is 5.40%. All told, it is clear that, ABT needs to be on your watchlist.

Find out when ABT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ABT has a short ratio of 1.59 and outstanding shares of 1.77B.

Company Outlook

ABT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 5.57 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 1.73. Investors should also keep an eye on sector updates as ABT has historically followed its peers on positive news.

All told, Abbott Laboratories ABT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ABT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Abbott Laboratories ABT is now commanding a market cap of 170.22B and a float of 1.76B. ABT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ABT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ABT, either long or short, and we have not been compensated for this article.

Latest article

Investor Confidence is Rising for Sientra Inc. (NASDAQ:SIEN)

Sientra Inc. (SIEN) shares are trading at higher $3.40 and the avg recommendation for the stock is Strong Buy. To add more color to...

TripAdvisor Inc. (NASDAQ:TRIP) is Gaining Momentum on Earnings Catalyst

TripAdvisor Inc. (TRIP) shares are trading at higher $19.59 and the avg recommendation for the stock is Hold, while the current analyst price target...

The Rejuvenation of Chewy Inc. (NYSE:CHWY)

Chewy Inc. (CHWY) shares are trading at lower $54.83 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Precigen Inc. (NASDAQ:PGEN) Recent Earnings Shows Major Concern

Precigen Inc. (PGEN) shares are trading at lower $3.50 and the avg recommendation for the stock is Moderate Buy. To add more color to...

The Unprecedented Rise of Duke Realty Corporation (NYSE:DRE)

Duke Realty Corporation (DRE) shares are trading at lower $36.90 and the avg recommendation for the stock is Moderate Buy, while the current analyst...